View of Effect of teriparatide (PTH 1–34) on fusion mass and clinical outcomes the year after single-level instrumented posterolateral fusion

Return to Article Details Effect of teriparatide (PTH 1–34) on fusion mass and clinical outcomes the year after single-level instrumented posterolateral fusion Download Download PDF